Acorda Therapeutics reported $393.34M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
Acorda Therapeutics ACOR:US USD 393.34M 12.97M
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
ALKERMES ALKS:US USD 1.94B 15.52M
Amgen AMGN:US USD 63.7B 4.41B
Anika Therapeutics ANIK:US USD 347.75M 6.38M
Aptinyx Inc APTX:US USD 76.2M 16.1M
Arrowhead Research ARWR:US USD 691.94M 59.84M
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Cara Therapeutics CARA:US USD 213.51M 13.06M
Clovis Oncology CLVS:US USD 346.78M 46.08M
Cytokinetics CYTK:US USD 1.08B 304.24M
Enanta Pharmaceuticals ENTA:US USD 375.41M 9.8M
Gilead Sciences GILD:US USD 62.56B 313M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Halozyme Therapeutics HALO:US USD 1.86B 83.15M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Insmed INSM:US USD 994.82M 58.54M
Ligand Pharmaceuticals LGND:US USD 1.05B 25.68M
Mannkind MNKD:US USD 293.84M 8.04M
Merck MRK:GR EUR 50.93B 2.22B
Moderna Inc MRNA:US USD 26.06B 13M
Neurocrine Biosciences NBIX:US USD 2.14B 137.7M
Novartis NOVN:VX USD 118.46B 4.45B
Teva Pharmaceutical TEVA:IT USD 44.25B 1.68B
Ultragenyx Pharmaceutical RARE:US USD 1.62B 297.85M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B